Injective Advances Regulatory Efforts for Tokenized Securities in US
Injective is making regulatory progress for tokenized securities and institutional onchain finance in the US.
Injective is making regulatory progress for tokenized securities and institutional onchain finance in the US. Injective (INJ) is trading at $7.58, down 0.7% since this brief published. This is an original TLT brief based on reporting by CaptainAltcoin, with live market data added, as of Sat, 24 Oct 2026 15:00:04 UTC.
This development is significant as it positions Injective to potentially bridge traditional finance and blockchain-based securities, subject to regulatory approval. It could open new institutional adoption pathways for tokenized assets.
- Injective met with US regulatory bodies including the SEC and CFTC.
- CEO Eric Chen led discussions on tokenized securities and institutional finance.
- INJ price down 3.92% in past 24 hours amid broader market decline.
- Injective Token Surges 25% Weekly Amid US Regulatory Talks and Institutional Interest
- Injective Advances Pineapple’s On-chain Strategy Amidst INJ Price Momentum
- Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement
- Injective Advances Regulatory Efforts for Tokenized Securities in US — this brief
Injective is making strategic regulatory moves in the United States to facilitate its expansion into tokenized securities and institutional onchain finance. According to CaptainAltcoin, the company's CEO Eric Chen recently led a delegation that included legal, policy, and research team members in meetings with key regulatory bodies in Washington.
The discussions involved officials from the White House, Securities and Exchange Commission (SEC), and Commodity Futures Trading Commission (CFTC). These meetings follow previous regulatory engagements, indicating a sustained effort by Injective to navigate the complex US regulatory landscape for blockchain-based financial products.
While the exact outcomes of these meetings are not yet clear, the proactive regulatory approach suggests Injective is preparing for potential expansion in the tokenized securities space. This could position the platform to attract more institutional users and increase its presence in traditional finance markets.
Injective's native token INJ is currently priced at $7.63, having fallen 3.92% in the past 24 hours and 11.64% over the last week. The broader crypto market is also experiencing a downturn, with the total market cap at $2.77 trillion and the Fear & Greed Index at 51, indicating a neutral sentiment.
The development highlights the growing intersection between blockchain technology and traditional finance. As Injective continues its regulatory engagements, market participants will be watching for further developments that could indicate the timing and scope of its institutional expansion plans.
Since this brief published about 1 hour ago, Injective (INJ) has moved from $7.63 to $7.58 — -0.66%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from TLT's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₦10,482.23 (about $7.58), down 3.8% over 24 hours. The naira itself trades about 4.0% above the official rate on the P2P market, so a Nigerian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · October 24, 2026.
TLT reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective Advances Regulatory Efforts for Tokenized Securiti — questions & answers
What regulatory bodies did Injective meet with?
Injective met with officials from the White House, SEC, and CFTC.
Why is Injective pursuing regulatory engagement?
To facilitate its expansion into tokenized securities and institutional onchain finance.
How has the INJ token performed recently?
INJ is down 3.92% in 24 hours and 11.64% over the past week.
How much is 1 Injective worth in naira today?
About ₦10,482.23 at the live peer-to-peer (P2P) USDT rate, which is what Nigerians typically trade at — equivalent to roughly $7.58. The naira price moves with both INJ's US-dollar price and the USDT/NGN rate; use our Injective in naira page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 0.66% since this brief first published — trading at $7.58 now versus $7.63 at publication. TLT re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original TLT brief that synthesises reporting from CaptainAltcoin. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original TLT brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.